CLDX · Celldex Therapeutics, Inc.
Market Cap
$3.12B
Shares
78.53M
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Debt data is being processed. Please check back later.
Key facts
CIK
744218
CUSIP
15117B202
13F (30d)
182 filings
182 filers
Visit website
Investor relations